#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Trigeminal neuralgia Myeloproliferative neoplasm Oesophageal achalasia Tuberous sclerosis complex Chronic cutaneous lupus erythematosus Nephroblastoma Craniocerebral injury Hepatic cirrhosis Waldenstrom's macroglobulinaemia refractory Cutaneous T-cell lymphoma recurrent Follicular lymphoma Lennox-Gastaut syndrome Primary biliary cholangitis Adenomatous polyposis coli Barth syndrome More trials…

    Learn about Rare Diseases

    Alport’s syndrome – Diagnostics Medulloblastoma – Diagnostics Sarcoma – Life with Disease Methylmalonic acidaemia – Diagnostics Hereditary angioedema – Life with Disease Ornithine transcarbamoylase deficiency – Basic Information Idiopathic inflammatory myopathy – Diagnostics Synovial sarcoma – Life with Disease Haemophilia – Diagnostics Angelman’s syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    BLEXIMENIB Dostarlimab Tirbanibulin Lasn01 HYDROMORPHONE HYDROCHLORIDE 6QC-ICG Maraviroc Fluorouracil Quercetin Resamirigene Bilparvovec Ag13909 Volixibat Betaine Citrate Vincristine Sulfate ANUMIGILIMAB Macitentan Dapagliflozin Bay 2927088 Milnacipran Hydrochloride Inclisiran More therapies…

    Learn about Your Condition

    Inflammation Radiation skin injury Senile dementia Papulopustular rosacea Autism spectrum disorder Endometrial cancer recurrent Ehlers-Danlos syndrome Pleural mesothelioma Diabetic ketoacidosis Neonatal anoxia HER2 positive gastric cancer Systemic sclerosis pulmonary Tetanus Skin ulcer Drug eruption More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • A study to evaluate the safety of brimonidine tartrate gel in preventing hand and foot syndrome in patients with colorectal or breast cancer treated with capecitabine

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Brimonidine Tartrate
    France

  • Comparison of amoxicillin, amoxicillin-clavulanate, and placebo for the treatment of middle ear infection in children

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Otitis media
    Investigated Drugs:
    • Clavulanic Acid
    • Amoxicillin
    Finland

  • A study to evaluate the safety and effectiveness of MRNA3771 and GRNA1599 in adults with chronic hepatitis B

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • GRNA1599
    France

  • Study of the effects of Ibutamoren Mesilate in prepubertal children with growth hormone deficiency

    Not yet recruiting

    3 1
    Investigated Drugs:
    • Ibutamoren Mesilate
    France Italy Poland Romania Spain

  • A study to evaluate the safety and effectiveness of oxaliplatin delivered directly to the liver for patients with colorectal cancer and liver metastasis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Oxaliplatin
    Belgium

  • A study to evaluate the safety and effectiveness of PTT-4256 and nivolumab in patients with solid tumors.

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Renal cell carcinoma
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Nivolumab
    France Spain
Previous Page
1 … 738 739 740 741 742 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!